Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.
Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
Glial influences on BBB functions and molecular players in immune cell trafficking.
[Anti-myelin oligodendrocyte glycoprotein (MOG) antibody].
Us Rrms Patient Preferences for Multiple Sclerosis Treatments: An Online Survey.
Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.
[Diagnostic criteria for neuromyelitisoptica spectrum disorders].
Impaired retinal microcirculation in multiple sclerosis.
Clinical outcome measures in multiple sclerosis.
Mortality of patients with multiple sclerosis: a cohort study in UK primary care.
Uric acid: a potential biomarker of multiple sclerosis and of its disability.
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.
Anti-CCP Antibody Levels Are Not Associated with MS: Results from a Case-Control Study.
Modeling cognition and disease using human glial chimeric mice.
Tablet-based screening improves continence management in multiple sclerosis.
The habenula and iron metabolism in cerebral mouse models of multiple sclerosis.
Medications Are Associated with Falls in People with Multiple Sclerosis: A Prospective Cohort Study.
Oxidative stress in multiple sclerosis: Central and peripheral mode of action.
Herpes Simplex Virus-related Transverse Myelitis and Polyneuritis.
Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.
Comparison of ActiGraph activity monitors in persons with multiple sclerosis and controls.
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis.
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis.
Virtual Sensory Feedback for Gait Improvement in Neurological Patients.
Pages
« first
‹ previous
…
623
624
625
626
627
628
629
630
631
…
next ›
last »